Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians

Pramesh, C.S.; Babu, Giridhara R; Basu, J.; Bhushan, Indu; Booth, Christopher M.; Chinnaswamy, Girish; Guleria, Randeep; Kalantri, Shriprakash; Kang, Gagandeep; Mohan, Pavitra; Mor, Nachiket; Prakash, Manu; Rupali, Priscilla; Sampathkumar, Priya; Sengar, Manju; Sullivan, Richard; Ranganathan, Priya

doi:10.1038/s41591-021-01439-x

Cited by 16 publications

(15 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Vaccination is recommended for preventing reinfection in patients with previous SARS‐CoV‐2 infection 10 . Cavanaugh et al 11 reported that full vaccination provides additional protection against reinfection among persons with previous SARS‐CoV‐2 infection.…”

Section: Introductionmentioning

confidence: 99%

Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID

Tsuchida

Hirose

Inoue

et al. 2022

Journal of Medical Virology

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID‐19) is spreading worldwide; there is a need to address its sequelae known as Long COVID. This study evaluated postvaccination changes in symptoms and antibody titers in patients with Long COVID. Patients visiting the outpatient department specializing in Long COVID at our hospital were enrolled. Changes in symptoms were evaluated before and 14–21 days after first vaccination. Antibody titers were measured using ARCHITECT SARS‐CoV‐2 IgG II Quant at the same time. This study included 42 patients (median age: 45 years; 17 [40.5%] men). Median pre‐ and postvaccination antibody titers were 456 and 28,963 AU/ml, respectively. Postvaccination symptoms (fatigue, joint pain, and taste and olfactory abnormalities) were relieved, worsened, and unchanged in 7 (16.7%), 9 (21.4%), and 26 (61.9%) patients, respectively. Ratios of pre‐ and postvaccination antibody titers were 53, 40, and 174 in the unchanged, relief, and worsened groups, respectively. The worsened group had the significantly highest antibody titer ratio ( p = 0.02). The higher increased rate of the antibody titer in the worsened group than in the nonworsened group suggests an excessive immune response to vaccination associated with worsening of sequelae. Although patients with Long COVID should be vaccinated, additional concerns should be addressed.

show abstract

Section: Introductionmentioning

confidence: 99%

Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID

Tsuchida

Hirose

Inoue

et al. 2022

Journal of Medical Virology

View full text Add to dashboard Cite

show abstract

“…Beneficial knowledge about COVID-19 aetiology, pathophysiology, prevention, vaccination, treatment and care has rapidly advanced through rigorous scientific, medical and public health inquiry, debate and collaboration [53][54][55][56] . Notwithstanding these advances, the responses of individual countries have been heterogeneous and often inade quate, in part because they lack coordination and clear goals.…”

mentioning

confidence: 99%

A multinational Delphi consensus to end the COVID-19 public health threat

Lazarus

Romero²,

Kopka³

et al. 2022

Nature

Self Cite

153

View full text Add to dashboard Cite

Despite notable scientific and medical advances, broader political, socioeconomic and behavioural factors continue to undercut the response to the COVID-19 pandemic1,2. Here we convened, as part of this Delphi study, a diverse, multidisciplinary panel of 386 academic, health, non-governmental organization, government and other experts in COVID-19 response from 112 countries and territories to recommend specific actions to end this persistent global threat to public health. The panel developed a set of 41 consensus statements and 57 recommendations to governments, health systems, industry and other key stakeholders across six domains: communication; health systems; vaccination; prevention; treatment and care; and inequities. In the wake of nearly three years of fragmented global and national responses, it is instructive to note that three of the highest-ranked recommendations call for the adoption of whole-of-society and whole-of-government approaches1, while maintaining proven prevention measures using a vaccines-plus approach2 that employs a range of public health and financial support measures to complement vaccination. Other recommendations with at least 99% combined agreement advise governments and other stakeholders to improve communication, rebuild public trust and engage communities3 in the management of pandemic responses. The findings of the study, which have been further endorsed by 184 organizations globally, include points of unanimous agreement, as well as six recommendations with >5% disagreement, that provide health and social policy actions to address inadequacies in the pandemic response and help to bring this public health threat to an end.

show abstract

“…From the beginning, different organizations developed sets of COVID-19 recommendations based on the usual choice of campaigns to reduce low-value practices. 10 Regrettably, the only publication of these recommendations did not guarantee their implementation. The use of multicomponent interventions targeting clinicians proved to be more effective than the dissemination of recommendations to reduce the use of low-value health services.…”

Section: Knowledge Factorsmentioning

confidence: 99%

Tools to Reduce Low-Value Care: Lessons From COVID-19 Pandemic Comment on "Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands"

Corral‐Gudino

2022

Int J Health Policy Manag

View full text Add to dashboard Cite

Based on a summary of interviews with 18 experts, Verkerk et al. defined the seven key factors that promoted low-value care, which included system, social, and knowledge factors. During the ongoing COVID-19 pandemic, these key factors have been influential due to the uncertainty of the disease at the beginning of the pandemic. Globally, several measures have been implemented to reduce low-value care practices and promote high-value care for COVID-19 patients. From huge multicenter, non-industry sponsored or multiplatform trials, to the use of social networks sites is an indispensable and effective way to disseminate medical information. Thanks to these measures, we have transformed a scenario of ignorance into an evidence-based medical scenario in less than a year. Verkerk et al.’s proposed key factors are an excellent framework for characterizing and highlighting the lessons that can be learnt from how we have fought against the pandemic and low-value practices.

show abstract

Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians

Cited by 16 publications

References 5 publications

Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID

Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID

A multinational Delphi consensus to end the COVID-19 public health threat

Tools to Reduce Low-Value Care: Lessons From COVID-19 Pandemic Comment on "Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands"

Contact Info

Product

Resources

About